Dmitry Balyasny Balyasny Asset Management
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPCX
SpaceX
SPCX
|
+$577M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$538M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$517M |
| 4 |
Texas Instruments
TXN
|
+$413M |
| 5 |
Roku
ROKU
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HOLX
Hologic
HOLX
|
+$357M |
| 2 |
Meta Platforms (Facebook)
META
|
+$326M |
| 3 |
Johnson Controls International
JCI
|
+$303M |
| 4 |
Applied Materials
AMAT
|
+$285M |
| 5 |
CTRA
Coterra Energy
CTRA
|
+$285M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.69% |
| 2 | Industrials | 9.96% |
| 3 | Consumer Discretionary | 8.03% |
| 4 | Healthcare | 7.46% |
| 5 | Financials | 6.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
Grand Canyon Education
LOPE
$3.84B
| $12.1M | 0.02% |
+84,670
| New | +$13.4M |
|
927
Exponent
EXPO
$3.34B
| $12.1M | 0.02% |
+206,154
| New | +$12.7M |
|
928
Kratos Defense & Security Solutions
KTOS
$10.7B
| $12.1M | 0.02% |
+242,350
| New | +$14.7M |
|
929
PUT
BP
BP
$115B
| $12.1M | 0.02% |
326,600
-141,000
| -30% | -$6.19M |
|
930
Erasca
ERAS
$6.17B
| $12.1M | 0.02% |
658,175
-4,485,810
| -87% | -$64.2M |
|
931
EXL Service
EXLS
$5.69B
| $12M | 0.02% |
+465,216
| New | +$13.7M |
|
932
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$33.1B
| $12M | 0.02% |
+110,100
| New | +$12M |
|
933
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17.8B
| $12M | 0.02% |
150,000
| – | – |
|
|
VNET
934
VNET Group
VNET
$1.91B
| $12M | 0.01% |
1,491,098
-5,300,513
| -78% | -$48.1M |
|
935
Crescent Energy
CRGY
$4.65B
| $11.9M | 0.01% |
1,215,413
+34,711
| +3% | +$424K |
|
936
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$5.07B
| $11.9M | 0.01% |
305,101
+223,650
| +275% | +$8.94M |
|
937
PUT
Las Vegas Sands
LVS
$30.5B
| $11.8M | 0.01% |
255,500
+223,100
| +689% | +$11.6M |
|
938
PUT
Deere & Co
DE
$175B
| $11.8M | 0.01% |
18,600
-13,000
| -41% | -$7.53M |
|
|
SEPN
939
Septerna Inc
SEPN
$1.87B
| $11.7M | 0.01% |
350,442
+113,763
| +48% | +$3.23M |
|
940
Capricor Therapeutics
CAPR
$366M
| $11.7M | 0.01% |
486,836
+189,713
| +64% | +$5.75M |
|
941
United Rentals
URI
$68.4B
| $11.7M | 0.01% |
10,344
+6,292
| +155% | +$5.99M |
|
942
Axogen
AXGN
$2.71B
| $11.7M | 0.01% |
253,498
-833,568
| -77% | -$33.6M |
|
943
PUT
Campbell Soup
CPB
$7.14B
| $11.7M | 0.01% |
+525,000
| New | +$11.1M |
|
944
Xenon Pharmaceuticals
XENE
$5.88B
| $11.7M | 0.01% |
193,407
-40,498
| -17% | -$2.25M |
|
|
GLXY
945
Galaxy Digital Inc
GLXY
$4.59B
| $11.6M | 0.01% |
425,809
+57,600
| +16% | +$1.6M |
|
946
HNI Corp
HNI
$3.55B
| $11.6M | 0.01% |
287,926
+207,437
| +258% | +$7.06M |
|
947
Reinsurance Group of America
RGA
$15.9B
| $11.6M | 0.01% |
54,625
-104,220
| -66% | -$21.7M |
|
948
BlackRock Corporate High Yield Fund
HYT
$1.34B
| $11.5M | 0.01% |
1,346,860
-901,933
| -40% | -$7.74M |
|
949
Verizon
VZ
$205B
| $11.5M | 0.01% |
272,201
+164,180
| +152% | +$7.7M |
|
950
Integra LifeSciences
IART
$1.3B
| $11.5M | 0.01% |
640,666
-53,410
| -8% | -$747K |
|
Similar funds
Dmitry Balyasny's Q2 2026 Portfolio in Review
As of Q2 2026, Dmitry Balyasny held 3,665 positions worth $80.2B, up 4% from $77.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Dmitry Balyasny withdrew a net $7.14B in Q2 2026, closing 734 positions and reducing 995 holdings. Its most notable exit was Hologic, an estimated $357M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 9.7% a quarter earlier, followed by Industrials and Consumer Discretionary.
Against the trend, Dmitry Balyasny opened a new position in SpaceX worth $581M.
- Dmitry Balyasny's largest Q2 2026 buy was SpaceX: 3,397,642 shares worth $581M.
- Dmitry Balyasny added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $538M increase.
- Dmitry Balyasny's biggest Q2 2026 reduction was Meta Platforms (Facebook), cutting an estimated $326M.
- Dmitry Balyasny fully exited Hologic in Q2 2026, selling an estimated $357M.
- Dmitry Balyasny's ten largest holdings make up 14% of its $80.2B portfolio in Q2 2026.
- Dmitry Balyasny opened 834 new positions and closed 734 in Q2 2026.
- Dmitry Balyasny's portfolio value rose 4% quarter-over-quarter to $80.2B.
Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.